Coagulopathies and thrombosis: Usual and unusual causes and associations, part IV

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 3, 2011, Pages 175-180

  Lippi, Giuseppe ^a   Favaloro, Emmanuel J ^b   Franchini, Massimo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5 LEIDEN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ATHEROGENESIS; BLOOD CLOTTING DISORDER; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; ENTERITIS; GAMMOPATHY; HEMOSTASIS; HUMAN; LUNG EMBOLISM; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; SLEEP APNEA SYNDROME; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANEMIA, SICKLE CELL; BLOOD COAGULATION DISORDERS; DIET; FEMALE; HEMOGLOBINURIA, PAROXYSMAL; HEPARIN; HUMANS; INFECTION; INFLAMMATORY BOWEL DISEASES; MALE; MOUTH DISEASES; MULTIPLE MYELOMA; SLEEP APNEA, OBSTRUCTIVE; THROMBOCYTOPENIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 79953654317     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1273081     Document Type: Review

References (30)

1. Franchini M, Lippi G, Favaloro E J. Coagulopathies and thrombosis: usual and unusual causes and associations, part I. Semin Thromb Hemost 2009 35 3 257-259
2. Lippi G, Franchini M, Favaloro E J. Coagulopathies and thrombosis: usual and unusual causes and associations, part II. Semin Thromb Hemost 2009 35 7 591-595
3. Favaloro E J., Lippi G, Franchini M. Coagulopathies and thrombosis: usual and unusual causes and associations, part III. Semin Thromb Hemost 2010 36 1 1-5
4. Zoellner H. Dental infection and vascular disease. Semin Thromb Hemost 2011 37 3 181-192
5. Tormene D, Ferri V, Carraro S, Simioni P. Gender and the risk of venous thromboembolism. Semin Thromb Hemost 2011 37 3 193-198
6. Zuern C S., Lindemann S, Gawaz M. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management. Semin Thromb Hemost 2009 35 3 295-306
7. Phang M, Lazarus S, Wood L G., Garg M. Diet and thrombosis risk: nutrients for prevention of thrombotic disease. Semin Thromb Hemost 2011 37 3 199-208
8. Lippi G, Franchini M, Favaloro E J., Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the French paradox Semin Thromb Hemost 2010 36 1 59-70
9. Zamagni E, Brioli A, Tacchetti P, Cavo M. Multiple myeloma, venous thromboembolism and treatment related risk of thrombosis. Semin Thromb Hemost 2011 37 3 209-219
10. Di Fabio F, Lykoudis P, Gordon P H. Venous and arterial thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance. Semin Thromb Hemost 2011 37 3 220-225
11. De Franceschi L, Cappellini M D., Olivieri O. Thrombosis and sickle cell disease. Semin Thromb Hemost 2011 37 3 226-236
12. Lippi G, Favaloro E J., Cervellin G. Prevention of venous thromboembolism: focus on mechanical prophylaxis. Semin Thromb Hemost 2011 37 3 237-251
13. Tufano A, Coppola A, Cerbone A M., Ruosi C, Franchini M. Preventing post-surgical thrombosispharmacological approaches. Semin Thromb Hemost 2011 37 3 252-266
14. Tufano A, Guida A, Di Minno MNDM, Prisco D, Cerbone A M., Di Minno G. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. Semin Thromb Hemost 2011 37 3 267-274
15. Bertina R M., Koeleman B P., Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994 369 6475 64-67 (Pubitemid 24144355)
16. Franchini M, Lippi G, Factor V. Leiden in women: a thrombotic risk factor or an evolutionary advantage? Semin Thromb Hemost 2011 37 3 275-279
17. Fava C, Montagnana M, Favaloro E J., Guidi G C., Lippi G. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost 2011 37 3 280-297
18. Bikdeli B, Sharif-Kashani B, Chitsaz E et al. Dexter DVT versus sinister DVT: which is the more sinister? Findings from the NRITLD DVT Registry. Semin Thromb Hemost 2011 37 3 305-314
19. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost 2009 35 4 426-438
20. Bereczky Z, Muszbek L. Factor XIII and venous thromboembolism. Semin Thromb Hemost 2011 37 3 000-000
21. Muszbek L, Bereczky Z, Bagoly Z, Shemirani A H., Katona E. Factor XIII and atherothrombotic diseases. Semin Thromb Hemost 2010 36 1 18-33
22. Weitz I C. Paroxysmal nocturnal hemoglobinuria (PNH) and thrombosis. Semin Thromb Hemost 2011 37 3 315-321
23. Walenga J M., Jackson C M., Kessler C M. Low molecular weight heparins differ substantially: impact on developing biosimilar drugs. Semin Thromb Hemost 2011 37 3 000-000
24. Jeske W P., Walenga J M., Hoppensteadt D A. et al. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins. Semin Thromb Hemost 2008 34 1 74-85 (Pubitemid 351640883)
25. Lassila R, Antovic J P., Armstrong E et al. Practical viewpoints on the diagnosis and management of heparin induced thrombocytopenia. Semin Thromb Hemost 2011 27 3 328-336
26. Girolami B, Girolami A. Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost 2006 32 8 803-809 (Pubitemid 44956975)
27. Prechel M, Walenga J M. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update. Semin Thromb Hemost 2008 34 1 86-96 (Pubitemid 351640884)
28. Favaloro E J. Editorial. Winners of the Inaugural Eberhard F. Mammen Award for most popular article. Semin Thromb Hemost 2009 35 587-590
29. Favaloro E J. Editorial. Winners of the 2010 Eberhard F. Mammen Award for most popular article during 2008-2009. Semin Thromb Hemost 2010 36 685-692
30. Favaloro E J. Editorial. Farewell to 2010! Semin Thromb Hemost 2010 36 797-802